Dirk Reinhardt combines Internal medicine and Gastroenterology in his studies. His work blends Gastroenterology and Internal medicine studies together. In his research, Dirk Reinhardt performs multidisciplinary study on Gene and Cell biology. Dirk Reinhardt integrates Cell biology with Gene in his research. Dirk Reinhardt integrates many fields in his works, including Myeloid leukemia and Leukemia. In his works, Dirk Reinhardt performs multidisciplinary study on Leukemia and Cancer research. As part of his studies on Cancer research, he often connects relevant subjects like Myeloid. As part of his studies on Myeloid, he often connects relevant subjects like Immunology. His research links Myeloid leukemia with Immunology.
His study on Internal medicine is intertwined with other disciplines of science such as Endocrinology, Oncology, Gastroenterology, Pediatrics and Surgery. Dirk Reinhardt performs integrative study on Endocrinology and Internal medicine. His Genetics research spans across into areas like Gene, Cancer research and Immunology. He performs multidisciplinary study in the fields of Gene and Genetics via his papers. His Cancer research study frequently draws parallels with other fields, such as Myeloid leukemia. His work on Myeloid leukemia expands to the thematically related Immunology. Dirk Reinhardt undertakes multidisciplinary investigations into Leukemia and Myeloid in his work. While working on this project, he studies both Myeloid and Leukemia.
Dirk Reinhardt conducts interdisciplinary study in the fields of Gene and Chromosomal translocation through his works. His work on Cell growth expands to the thematically related Genetics. In his research, he undertakes multidisciplinary study on Cell growth and Gene. As part of his studies on Cancer research, Dirk Reinhardt often connects relevant areas like Myeloid. He applies his multidisciplinary studies on Myeloid and Leukemia in his research. He performs multidisciplinary study in the fields of Leukemia and Myeloid leukemia via his papers. He combines topics linked to Cancer research with his work on Myeloid leukemia. His research is interdisciplinary, bridging the disciplines of Milk allergy and Immunology. He performs integrative Milk allergy and Food allergy research in his work.
Dirk Reinhardt combines Gene and Cell growth in his research. He frequently studies issues relating to Genetics and Cell growth. His research on Genetics often connects related topics like Suppressor. His Suppressor study frequently draws connections between adjacent fields such as Gene. Dirk Reinhardt integrates many fields in his works, including Leukemia and Cancer research. His research ties Myeloid leukemia and Cancer research together. His Myeloid leukemia study frequently links to related topics such as Immunology. In most of his Immunology studies, his work intersects topics such as Myeloid. In his research, he undertakes multidisciplinary study on Myeloid and Leukemia.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel.
Ursula Creutzig;Marry M. van den Heuvel-Eibrink;Brenda Gibson;Michael N. Dworzak.
Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study.
Brian V. Balgobind;Susana C. Raimondi;Susana C. Raimondi;Jochen Harbott;Martin Zimmermann.
Clinical implications of FLT3 mutations in pediatric AML
Soheil Meshinchi;Todd A. Alonzo;Derek L. Stirewalt;Michel Zwaan.
Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials.
Ursula Creutzig;M. Zimmermann;J. Ritter;D. Reinhardt.
Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia
B F Goemans;Ch M Zwaan;Ch M Zwaan;M Miller;M Zimmermann.
Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia
C. Michel Zwaan;Edward A. Kolb;Dirk Reinhardt;Jonas Abrahamsson.
Journal of Clinical Oncology (2015)
Treatment and prognostic impact of transient leukemia in neonates with Down syndrome
Jan-Henning Klusmann;Ursula Creutzig;Martin Zimmermann;Michael Dworzak.
Early Deaths and Treatment-Related Mortality in Children Undergoing Therapy for Acute Myeloid Leukemia: Analysis of the Multicenter Clinical Trials AML-BFM 93 and AML-BFM 98
Ursula Creutzig;Martin Zimmermann;Dirk Reinhardt;Michael Dworzak.
Journal of Clinical Oncology (2004)
Prognostic Impact of Specific Chromosomal Aberrations in a Large Group of Pediatric Patients With Acute Myeloid Leukemia Treated Uniformly According to Trial AML-BFM 98
Christine von Neuhoff;Dirk Reinhardt;Annette Sander;Martin Zimmermann.
Journal of Clinical Oncology (2010)
Improved Treatment Results in High-Risk Pediatric Acute Myeloid Leukemia Patients After Intensification With High-Dose Cytarabine and Mitoxantrone: Results of Study Acute Myeloid Leukemia–Berlin-Frankfurt-Münster 93
U Creutzig;J Ritter;M Zimmermann;D Reinhardt.
Journal of Clinical Oncology (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: